CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 199 filers reported holding CLOVIS ONCOLOGY INC in Q3 2015. The put-call ratio across all filers is 0.94 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $10,141,000 | -45.1% | 528,188 | 0.0% | 0.40% | -22.6% |
| Q4 2015 | $18,487,000 | -67.5% | 528,188 | -14.6% | 0.52% | -71.1% |
| Q3 2015 | $56,849,000 | +4.6% | 618,188 | 0.0% | 1.80% | +22.4% |
| Q2 2015 | $54,326,000 | +18.4% | 618,188 | 0.0% | 1.47% | +7.8% |
| Q1 2015 | $45,888,000 | +32.6% | 618,188 | 0.0% | 1.37% | +21.9% |
| Q4 2014 | $34,619,000 | +36.7% | 618,188 | +10.7% | 1.12% | +8.9% |
| Q3 2014 | $25,319,000 | +9.5% | 558,188 | 0.0% | 1.03% | -6.3% |
| Q2 2014 | $23,115,000 | -31.6% | 558,188 | +14.3% | 1.10% | -37.0% |
| Q1 2014 | $33,817,000 | +14.9% | 488,188 | 0.0% | 1.74% | +10.9% |
| Q4 2013 | $29,423,000 | +26.7% | 488,188 | +27.8% | 1.57% | +24.5% |
| Q3 2013 | $23,219,000 | – | 381,886 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |